Related references
Note: Only part of the references are listed.A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis
Devin Incerti et al.
PHARMACOECONOMICS (2019)
Increasing the Transparency of Research Papers with Explorable Multiverse Analyses
Pierre Dragicevic et al.
CHI 2019: PROCEEDINGS OF THE 2019 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (2019)
Benefits, Challenges and Potential Strategies of Open Source Health Economic Models
William C. N. Dunlop et al.
PHARMACOECONOMICS (2017)
Data Sharing Statements for Clinical Trials A Requirement of the International Committee of Medical Journal Editors
Darren B. Taichman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Finding Resolution for the Responsible Transparency of Economic Models in Health and Medicine
William V. Padula et al.
MEDICAL CARE (2017)
Can Economic Model Transparency Improve Provider Interpretation of Cost-effectiveness Analysis? Evaluating Tradeoffs Presented by the Second Panel on Cost-effectiveness in Health and Medicine
William V. Padula et al.
MEDICAL CARE (2017)
Can Economic Model Transparency Improve Provider Interpretation of Cost-Effectiveness Analysis? A Response
Joshua T. Cohen et al.
MEDICAL CARE (2017)
Data Authorship as an Incentive to Data Sharing
Barbara E. Bierer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Reproducibility in Computational Neuroscience Models and Simulations
Robert A. McDougal et al.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2016)
Economic evaluation in chronic pain: a systematic review and de novo flexible economic model
W. Sullivan et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2016)
Modeling Good Research Practices-Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
J. Jaime Caro et al.
MEDICAL DECISION MAKING (2012)
Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
David M. Eddy et al.
MEDICAL DECISION MAKING (2012)
Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
David M. Eddy et al.
VALUE IN HEALTH (2012)
Addressing the Challenge for Well Informed and Consistent Reimbursement Decisions The Case for Reference Models
Hossein Haji Ali Afzali et al.
PHARMACOECONOMICS (2011)
Nice transparency - Let cost effectiveness models be open to scrutiny
Chris Poole et al.
BRITISH MEDICAL JOURNAL (2007)
Share Paper
